Spruce Adult Study

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SPR001 (Tildacerfont) in Reducing Supraphysiologic Glucocorticoid Use in Adult Subjects with Classic Congenital Adrenal Hyperplasia
CHLA IRB Number
CHLA-21-00155
Study Type
Randomized
Eligibility
Adults
Clinical Trials Government Identifier
NCT04544410
Enrollment Status
Open
Does this study also recruit healthy volunteers?
No
Coordinator Contact
Norma Martinez
Contact Email
CAH@chla.usc.edu